ACET
Price
$0.61
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
50.2M
33 days until earnings call
SUPN
Price
$31.98
Change
-$0.09 (-0.28%)
Updated
Jul 3 closing price
Capitalization
1.84B
26 days until earnings call
Interact to see
Advertisement

ACET vs SUPN

Header iconACET vs SUPN Comparison
Open Charts ACET vs SUPNBanner chart's image
Adicet Bio
Price$0.61
Change-$0.00 (-0.00%)
Volume$545.98K
Capitalization50.2M
Supernus Pharmaceuticals
Price$31.98
Change-$0.09 (-0.28%)
Volume$212.57K
Capitalization1.84B
ACET vs SUPN Comparison Chart in %
Loading...
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SUPN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACET vs. SUPN commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACET is a Hold and SUPN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (ACET: $0.61 vs. SUPN: $31.98)
Brand notoriety: ACET and SUPN are both not notable
ACET represents the Biotechnology, while SUPN is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ACET: 99% vs. SUPN: 39%
Market capitalization -- ACET: $50.2M vs. SUPN: $1.84B
ACET [@Biotechnology] is valued at $50.2M. SUPN’s [@Pharmaceuticals: Other] market capitalization is $1.84B. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACET’s FA Score shows that 2 FA rating(s) are green whileSUPN’s FA Score has 0 green FA rating(s).

  • ACET’s FA Score: 2 green, 3 red.
  • SUPN’s FA Score: 0 green, 5 red.
According to our system of comparison, ACET is a better buy in the long-term than SUPN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACET’s TA Score shows that 4 TA indicator(s) are bullish while SUPN’s TA Score has 3 bullish TA indicator(s).

  • ACET’s TA Score: 4 bullish, 5 bearish.
  • SUPN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ACET is a better buy in the short-term than SUPN.

Price Growth

ACET (@Biotechnology) experienced а -9.48% price change this week, while SUPN (@Pharmaceuticals: Other) price change was +2.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.13%. For the same industry, the average monthly price growth was +3.08%, and the average quarterly price growth was +93.03%.

Reported Earning Dates

ACET is expected to report earnings on Aug 06, 2025.

SUPN is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Pharmaceuticals: Other (+2.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SUPN($1.84B) has a higher market cap than ACET($50.2M). SUPN YTD gains are higher at: -11.560 vs. ACET (-36.902). SUPN has higher annual earnings (EBITDA): 90M vs. ACET (-110.82M). SUPN has more cash in the bank: 255M vs. ACET (150M). ACET has less debt than SUPN: ACET (16.2M) vs SUPN (41.5M). SUPN has higher revenues than ACET: SUPN (608M) vs ACET (0).
ACETSUPNACET / SUPN
Capitalization50.2M1.84B3%
EBITDA-110.82M90M-123%
Gain YTD-36.902-11.560319%
P/E RatioN/A1677.00-
Revenue0608M-
Total Cash150M255M59%
Total Debt16.2M41.5M39%
FUNDAMENTALS RATINGS
ACET vs SUPN: Fundamental Ratings
ACET
SUPN
OUTLOOK RATING
1..100
659
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
73
Overvalued
PROFIT vs RISK RATING
1..100
10070
SMR RATING
1..100
9780
PRICE GROWTH RATING
1..100
8959
P/E GROWTH RATING
1..100
21100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACET's Valuation (31) in the Medical Distributors industry is somewhat better than the same rating for SUPN (73) in the Pharmaceuticals Other industry. This means that ACET’s stock grew somewhat faster than SUPN’s over the last 12 months.

SUPN's Profit vs Risk Rating (70) in the Pharmaceuticals Other industry is in the same range as ACET (100) in the Medical Distributors industry. This means that SUPN’s stock grew similarly to ACET’s over the last 12 months.

SUPN's SMR Rating (80) in the Pharmaceuticals Other industry is in the same range as ACET (97) in the Medical Distributors industry. This means that SUPN’s stock grew similarly to ACET’s over the last 12 months.

SUPN's Price Growth Rating (59) in the Pharmaceuticals Other industry is in the same range as ACET (89) in the Medical Distributors industry. This means that SUPN’s stock grew similarly to ACET’s over the last 12 months.

ACET's P/E Growth Rating (21) in the Medical Distributors industry is significantly better than the same rating for SUPN (100) in the Pharmaceuticals Other industry. This means that ACET’s stock grew significantly faster than SUPN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACETSUPN
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
68%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 9 days ago
82%
Bullish Trend 3 days ago
73%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 8 days ago
66%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SUPN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IPA1.310.25
+23.58%
ImmunoPrecise Antibodies Ltd
QBTS16.790.81
+5.07%
D-Wave Quantum
SCS11.250.03
+0.27%
Steelcase
RHCGF1.21N/A
N/A
Ryman Healthcare Ltd.
IMDZF127.82N/A
N/A
IMCD NV

ACET and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACET has been loosely correlated with OGI. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ACET jumps, then OGI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACET
1D Price
Change %
ACET100%
-1.14%
OGI - ACET
41%
Loosely correlated
+3.62%
SYRE - ACET
41%
Loosely correlated
+1.68%
RGNX - ACET
39%
Loosely correlated
+1.39%
INBX - ACET
39%
Loosely correlated
N/A
DVAX - ACET
39%
Loosely correlated
+1.08%
More

SUPN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SUPN has been loosely correlated with DVAX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if SUPN jumps, then DVAX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SUPN
1D Price
Change %
SUPN100%
-0.28%
DVAX - SUPN
34%
Loosely correlated
+1.08%
COLL - SUPN
29%
Poorly correlated
-0.52%
SNDL - SUPN
27%
Poorly correlated
+1.60%
ACET - SUPN
27%
Poorly correlated
-1.14%
AQST - SUPN
27%
Poorly correlated
+1.09%
More